← Leaderboards
Phillip Randolph Torralva
Torralva Medical Therapeutics, Llc
$1,768,520
Attributed
$1,768,520
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $546.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,768,520 · 2
By mechanism
R44$1,393,884 · 1
R41$374,636 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Muscle Rigidity”
- Xinhua Li · Nano Terra, Inc.$6,202,588
- Paul Hanissian · Reia, Llc$5,185,645
- Krishna C Penumatsa · Tufts Medical Center$2,572,205
- Mattia Gazzola · University Of Illinois At Urbana-Champaign$2,439,200
- David A Matuskey · Yale University$2,029,333
- Darrin Jason Lee · University Of Southern California$1,361,258
Research focus
Muscle RigidityOff-Target SiteMorphineMu Opioid ReceptorsFentanyl OverdoseNaloxoneIn VitroMedicalChest Wall StructureEffective TherapyAnimal ModelFentanylFormulationHeroinAirway ObstructionDoseLipidsBiological ModelsBrainAnalogAffinityCessation Of LifeCenters For Disease Control And Prevention (U.S.)Opioid
Grant awards (6)
Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model.$446,782
R44 · FY2025 · DA · contact PI
Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model.$99,972
R44 · FY2025 · DA · contact PI
Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model.$522,934
R44 · FY2024 · DA · contact PI
Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model.$324,196
R44 · FY2022 · DA · contact PI
I-Corps Project plan for:STTR Phase I Development of therapeutics to treat fentanyl overdose using a validated animal model$54,960
R41 · FY2022 · DA · contact PI
Development of therapeutics to treat fentanyl overdose using a validated animal model$319,676
R41 · FY2021 · DA · contact PI